86 related articles for article (PubMed ID: 16515585)
1. BRCA1 expression in a large series of sporadic ovarian carcinomas: a Gynecologic Oncology Group study.
Thrall M; Gallion HH; Kryscio R; Kapali M; Armstrong DK; DeLoia JA
Int J Gynecol Cancer; 2006; 16 Suppl 1():166-71. PubMed ID: 16515585
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer 1 (BRCA1) protein expression as a prognostic marker in sporadic epithelial ovarian carcinoma: an NCIC CTG OV.16 correlative study.
Weberpals JI; Tu D; Squire JA; Amin MS; Islam S; Pelletier LB; O'Brien AM; Hoskins PJ; Eisenhauer EA
Ann Oncol; 2011 Nov; 22(11):2403-2410. PubMed ID: 21368065
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic characterization of hereditary epithelial ovarian cancer based on a tissue microarray study.
Muñoz-Repeto I; García MJ; Kamieniak M; Ramón Y Cajal T; Domingo S; Cazorla A; García Donas J; Hernando Polo S; García Sagredo JM; Hernández E; Lacambra C; Saez R; Robles L; Borrego S; Prat J; Palacios J; Benítez J
Histol Histopathol; 2013 Jan; 28(1):133-44. PubMed ID: 23233066
[TBL] [Abstract][Full Text] [Related]
4. No association between BRCA1 immunohistochemical expression and tumor grade, stage or overall survival in platinum-treated epithelial ovarian cancer patients.
Shawky Ael-A; El-Hafez AA; El-Tantawy D; Hamdy R
Asian Pac J Cancer Prev; 2014; 15(10):4275-9. PubMed ID: 24935384
[TBL] [Abstract][Full Text] [Related]
5. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.
Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I
J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer.
Carser JE; Quinn JE; Michie CO; O'Brien EJ; McCluggage WG; Maxwell P; Lamers E; Lioe TF; Williams AR; Kennedy RD; Gourley C; Harkin DP
Gynecol Oncol; 2011 Dec; 123(3):492-8. PubMed ID: 21920589
[TBL] [Abstract][Full Text] [Related]
7. Methylation status and immunohistochemistry of BRCA1 in epithelial ovarian cancer.
Pradjatmo H; Dasuki D; Anwar M; Mubarika S; Harijadi
Asian Pac J Cancer Prev; 2014; 15(21):9479-85. PubMed ID: 25422243
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 expression, proliferative and apoptotic activities in ovarian epithelial inclusions.
Wang Y; Wang Y; Wei L; Hong S; Zhao M; Zhang X; Zheng W
J Ovarian Res; 2017 Mar; 10(1):12. PubMed ID: 28270171
[TBL] [Abstract][Full Text] [Related]
9. Perturbation of Rb, p53, and Brca1 or Brca2 cooperate in inducing metastatic serous epithelial ovarian cancer.
Szabova L; Yin C; Bupp S; Guerin TM; Schlomer JJ; Householder DB; Baran ML; Yi M; Song Y; Sun W; McDunn JE; Martin PL; Van Dyke T; Difilippantonio S
Cancer Res; 2012 Aug; 72(16):4141-53. PubMed ID: 22617326
[TBL] [Abstract][Full Text] [Related]
10. No differences in p53 mutation frequencies between BRCA1-associated and sporadic ovarian cancers.
Aghmesheh M; Nesland JM; Kaern J; Dorum A; Edwards L; Byth K; Friedlander M; Jackson P; Tucker KM; Russell PJ
Gynecol Oncol; 2004 Dec; 95(3):430-6. PubMed ID: 15581943
[TBL] [Abstract][Full Text] [Related]
11. Reduction of BRCA1 expression in sporadic ovarian cancer.
Zheng W; Luo F; Lu JJ; Baltayan A; Press MF; Zhang ZF; Pike MC
Gynecol Oncol; 2000 Mar; 76(3):294-300. PubMed ID: 10684699
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 mRNA expression levels predict for overall survival in ovarian cancer after chemotherapy.
Quinn JE; James CR; Stewart GE; Mulligan JM; White P; Chang GK; Mullan PB; Johnston PG; Wilson RH; Harkin DP
Clin Cancer Res; 2007 Dec; 13(24):7413-20. PubMed ID: 18094425
[TBL] [Abstract][Full Text] [Related]
13. BRCA1 promoter hypermethylation and protein expression in ovarian carcinoma--an Indian study.
Shilpa V; Bhagat R; Premalata CS; Pallavi VR; Ramesh G; Krishnamoorthy L
Tumour Biol; 2014 May; 35(5):4277-84. PubMed ID: 24385383
[TBL] [Abstract][Full Text] [Related]
14. Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers.
Russell PA; Pharoah PD; De Foy K; Ramus SJ; Symmonds I; Wilson A; Scott I; Ponder BA; Gayther SA
Int J Cancer; 2000 Aug; 87(3):317-21. PubMed ID: 10897034
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
16. The BRCA1 Methylation and PD-L1 Expression in Sporadic Ovarian Cancer.
Zhu X; Zhao L; Lang J
Int J Gynecol Cancer; 2018 Oct; 28(8):1514-1519. PubMed ID: 30045136
[TBL] [Abstract][Full Text] [Related]
17. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.
Rosen DG; Wang L; Jain AN; Lu KH; Luo RZ; Yu Y; Liu J; Bast RC
Clin Cancer Res; 2004 Oct; 10(19):6559-66. PubMed ID: 15475444
[TBL] [Abstract][Full Text] [Related]
18. p53 mutations in epithelial ovarian cancers: possible role in predicting chemoresistance.
Laframboise S; Chapman W; McLaughlin J; Andrulis IL
Cancer J; 2000; 6(5):302-8. PubMed ID: 11079169
[TBL] [Abstract][Full Text] [Related]
19. The role of the breast cancer susceptibility gene 1 (BRCA1) in sporadic epithelial ovarian cancer.
McCoy ML; Mueller CR; Roskelley CD
Reprod Biol Endocrinol; 2003 Oct; 1():72. PubMed ID: 14613551
[TBL] [Abstract][Full Text] [Related]
20. Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases.
Yoshikawa K; Honda K; Inamoto T; Shinohara H; Yamauchi A; Suga K; Okuyama T; Shimada T; Kodama H; Noguchi S; Gazdar AF; Yamaoka Y; Takahashi R
Clin Cancer Res; 1999 Jun; 5(6):1249-61. PubMed ID: 10389907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]